Krzysztof Jóźwiak
Affiliations: | Department of Biopharmacy | Medical University of Lublin |
Google:
"Krzysztof Jóźwiak"Mean distance: (not calculated yet)
Children
Sign in to add traineePiotr Drączkowski | grad student | Medical University of Lublin | |
Karolina Pająk | grad student | Medical University of Lublin | |
Anita Płazińska | grad student | Medical University of Lublin | |
Ewelina Rutkowska | grad student | Medical University of Lublin | |
Katarzyna Targowska-Duda | grad student | Medical University of Lublin | |
Rafał Urniaż | grad student | Medical University of Lublin | |
Artur Wnorowski | grad student | 2011-2015 | Medical University of Lublin |
Anna Sroka-Bartnicka | post-doc | Medical University of Lublin | |
Maciej Maj | research scientist | Medical University of Lublin |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Plazinski W, Archala A, Jozwiak K, et al. (2024) Unraveling the Structural Basis of Biased Agonism in the β-Adrenergic Receptor Through Molecular Dynamics Simulations. Proteins |
Malek R, Sałat K, Totoson P, et al. (2024) Discovery of New Highly Potent Histamine H Receptor Antagonists, Calcium Channel Blockers, and Acetylcholinesterase Inhibitors. Acs Chemical Neuroscience |
Pachón-Angona I, Bernard PJ, Simakov A, et al. (2024) Design and Synthesis of Multi-Functional Ligands through Hantzsch Reaction: Targeting Ca Channels, Activating Nrf2 and Possessing Cathepsin S Inhibitory, and Antioxidant Properties. Pharmaceutics. 16 |
Zaręba P, Łątka K, Mazur G, et al. (2023) Discovery of novel multifunctional ligands targeting GABA transporters, butyrylcholinesterase, β-secretase, and amyloid β aggregation as potential treatment of Alzheimer's disease. European Journal of Medicinal Chemistry. 261: 115832 |
Dakhlaoui I, Bernard PJ, Pietrzak D, et al. (2023) Exploring the Potential of Sulfonamide-Dihydropyridine Hybrids as Multitargeted Ligands for Alzheimer's Disease Treatment. International Journal of Molecular Sciences. 24 |
Maciag M, Plazinski W, Pulawski W, et al. (2023) A comprehensive pharmacological analysis of fenoterol and its derivatives to unravel the role of β-adrenergic receptor in zebrafish. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 160: 114355 |
Malek R, Simakov A, Davis A, et al. (2022) Biginelli Reaction Synthesis of Novel Multitarget-Directed Ligands with Ca Channel Blocking Ability, Cholinesterase Inhibition, Antioxidant Capacity, and Nrf2 Activation. Molecules (Basel, Switzerland). 28 |
Wnorowski A, Dudzik D, Bernier M, et al. (2022) Deprogramming metabolism in pancreatic cancer with a bi-functional GPR55 inhibitor and biased β adrenergic agonist. Scientific Reports. 12: 3618 |
Pachón-Angona I, Maj M, Wnorowski A, et al. (2021) Synthesis of new Hantzsch adducts showing Ca channel blockade capacity, cholinesterase inhibition and antioxidant power. Future Medicinal Chemistry |
Targowska-Duda KM, Budzynska B, Michalak A, et al. (2021) Type I and type II positive allosteric modulators of α7 nicotinic acetylcholine receptors induce antidepressant-like activity in mice by a mechanism involving receptor potentiation but not neurotransmitter reuptake inhibition. Correlation with mTOR intracellular pathway activation. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 52: 31-47 |